(1S,4S)-1-(hydroxymethyl)-4-(4-(4-(((1S,4S)-1-(hydroxymethyl)-7-methyl-6,8-dioxo-2,3-dithia-5,7-diazabicyclo[2.2.2]octan-4-yl)methyl)phenethyl)benzyl)-5,7-dimethyl-2,3-dithia-5,7-diazabicyclo[2.2.2]octane-6,8-dione

ID: ALA4542925

Chembl Id: CHEMBL4542925

PubChem CID: 155551940

Max Phase: Preclinical

Molecular Formula: C29H32N4O6S4

Molecular Weight: 660.87

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1C(=O)[C@@]2(Cc3ccc(CCc4ccc(C[C@@]56SS[C@@](CO)(C(=O)N5C)N(C)C6=O)cc4)cc3)NC(=O)[C@]1(CO)SS2

Standard InChI:  InChI=1S/C29H32N4O6S4/c1-31-23(37)26(30-22(36)28(31,16-34)42-40-26)14-20-10-6-18(7-11-20)4-5-19-8-12-21(13-9-19)15-27-24(38)33(3)29(17-35,43-41-27)25(39)32(27)2/h6-13,34-35H,4-5,14-17H2,1-3H3,(H,30,36)/t26-,27-,28-,29-/m0/s1

Standard InChI Key:  UUONGCFZYQAMCW-DZUOILHNSA-N

Alternative Forms

  1. Parent:

    ALA4542925

    ---

Associated Targets(Human)

EP300 Tchem Histone acetyltransferase p300/Hypoxia-inducible factor 1-alpha (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EP300 Tchem Histone acetyltransferase p300 (1259 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 660.87Molecular Weight (Monoisotopic): 660.1205AlogP: 1.64#Rotatable Bonds: 9
Polar Surface Area: 130.49Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.20CX Basic pKa: CX LogP: 4.16CX LogD: 4.16
Aromatic Rings: 2Heavy Atoms: 43QED Weighted: 0.34Np Likeness Score: 0.67

References

1. Li J, Xi W, Li X, Sun H, Li Y..  (2019)  Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.,  27  (7): [PMID:30819620] [10.1016/j.bmc.2019.01.042]

Source